NHLBI Next Gen - Sickle Cell Anemia (Dr. Steinberg, Dr. Mostoslavsky, Dr. Murphy, Boston University and Boston Medical Center's Center for Regenerative Medicine)

Showing 49–60 of 60 results

Cell Line	Cell Line Alias	Cell Type	Disease	Genetic Alteration/Mutation	Sex	Age at Collection	Ethnicity	Genetically Related Cell Lines	dbGaP Data
CREM001i-bBU1C2	bBU1C2	Human iPS	None reported		Male	42 Years	Caucasian	No	Yes
CREM002i-BU2C10	BU2-15-Cre10	Human iPS	None reported		Male	45 Years	Caucasian	No	Yes
CREM003i-BU3C2	BU3-10-Cre02	Human iPS	None reported		Male	40 Years	Caucasian	No	Yes
CREM004i-SS2-1	SS2-1	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Female	32 Years	African American	No	Yes
CREM005i-SS2-1GAG	SCD iPSC SS.2-1-GAG, SS2-1GAG	Modified Human iPS	None reported	A>T mutation in beta globin gene reverted to A by CRISPRs	Female	32 Years	African American	No	Yes
CREM006i-SS4-1	SS4-1	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Male	30 Years	African American	No	Yes
CREM007i-SS5-1	SS5-1	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Male	32 Years	African American	No	Yes
CREM008i-SS6-1	SS6-1	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Female	24 Years	African American	Yes	Yes
CREM009i-SS8-2	SS8-2	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Female	31 Years	African American	No	Yes
CREM010i-SS9-1	SS9-1	Human iPS	Sickle cell anemia SS	A>T mutation in beta globin gene	Female	29 Years	African American	No	Yes

12…6